Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Blood pressure drugs can cause skin lupus, but it improves after stopping the drug. The glycoprotein D vaccine works against genital herpes in some women, and the HPV-16 vaccine reduces HPV-16 infection and related diseases. More frequent light therapy clears psoriasis faster. A cream called imiquimod effectively treats a type of skin cancer. Iron supplements don't necessarily help with chronic hair loss in women.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

UVB is good for a skin condition in Asian kids, a lotion works for head lice, a drug helps with a skin blistering disorder, a foam reduces itchiness in skin inflammation, birthmarks can be more widespread, and criteria for a neurocutaneous disorder were agreed upon.

EGFR inhibitors in breast cancer treatment can cause serious skin issues affecting patient quality of life.

Monocytes might be linked to hair loss after COVID-19.

People with hair loss are more likely to have anxiety.

Over half of the participants in a Saudi Arabian survey experienced hair loss after COVID-19, affecting women and younger people more, with a small percentage feeling a severe impact on their lives.

cGVHD often severely affects the skin, causing rapid aging and other issues.

Ban Tu Wan, a Chinese herbal supplement, can cause severe liver damage.

The study suggests that mast cells might be involved in the hair loss condition telogen effluvium and could be a target for treatment.

Topical minoxidil can cause severe liver failure.

Clouston syndrome can lead to skin cancer, so monitoring is crucial.

Understanding the cause of bitemporal hair loss is key to deciding the right treatment.

Weight loss can cause temporary hair loss, especially in women and older adults.

Color changes in Minoxidil hair products do not affect their effectiveness.

Thyroid dysfunction, vitamin D and B12 deficiencies, and iron deficiency may be linked to hair loss condition Telogen Effluvium.

The document concludes that various skin conditions have specific characteristics and treatments, and highlights the importance of vitamin D in managing these dermatological issues.

Androgenetic alopecia causes hair thinning due to increased androgen activity, treatable with minoxidil and finasteride.

Combining regenerative therapy with light treatment can effectively promote hair growth.

Telogen Effluvium causes increased hair shedding and can be challenging to diagnose and treat.

Mutations in the vitamin D receptor cause hereditary vitamin D-resistant rickets, leading to poor bone health and requiring high calcium doses for treatment.

Follicular mucinosis can be an early sign of aggressive mycosis fungoides.

A mouse gene mutation increases the risk of skin cancer.

Cronkhite-Canada syndrome is a rare, non-inherited condition causing various symptoms like polyps, hair loss, and weight loss.

COVID-19 can cause temporary hair loss, often starting around 7-8 weeks after recovery, with factors like Vitamin D deficiency, other diseases, medication, and stress potentially contributing.

The balance of thiol-disulfide in women with hair loss is affected but not damaged.

Menopause can cause hair loss in women due to hormonal changes, affecting their well-being and quality of life.

Adrenal tumors in hamsters are rare and hard to diagnose, highlighting the need for better diagnostic tools.

Chronic skin diseases and metabolic syndrome are linked by shared inflammation pathways.

Exosomes and PRP both show promise for hair loss treatment, but more research is needed.